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Background
Patients with schizophrenia and chronic substance abus-
ers often display deficits in working memory function
linked to prefrontal cortical dysfunction. Cortical
dopamine transmission strongly influences the efficiency
of capacity-constrained prefrontal activity. A recent fMRI
study showed that amphetamine modulates cortical
processing in line with an inverted-U type dose-response
function. Repeated intermittent exposure to ampheta-
mine in primates has been shown to result in augmenta-
tion of the behavioural response elicited by the drug (eg:
hyperlocomotion) known as sensitisation. Chronic treat-
ment produces cognitive deficits similar to those observed
in clinical populations and sensitisation is a well estab-
lished animal model of behavioural and neurochemical
aspects of schizophrenia. In this study we use fMRI to
examine the behavioural consequences and neural corre-
lates of working memory function in healthy volunteers
displaying behavioural sensitisation.
Materials and methods
Twenty-two participants were recruited and randomly
assigned to one of two groups. Group 1 received three
doses of d-Amphetamine with an inter-dose interval of 48
hours, and then a final fourth dose of d-Amphetamine
after a 14-day withdrawal period. Group 2 followed the
same experimental design but received only placebo in a
double blind design. All participants underwent fMRI
scanning on two occasions (session 1 and session 4) three
apart while performing a parametric verbal working mem-
ory task. Analysis was carried out using neuroimgaing sta-
tisitical SPM2.
Results
Amphetamine sensitisation results in an alteration in the
cortical response to amphetamine in the DLPFC in accord
with previous animal work. In individuals displaying sen-
sitisation cortical response to amphetamine was depend-
ent upon the initial response and was characterised by a
shift to the left of the inverted-U dose-response curve,
resulting in a reduction in DLPFC activation.
Discussion
The demonstration of neurofunctional changes in sensi-
tised humans which accord with observations in animals
validates these models of working memory dysfunction.
The cortical response to amphetamine following sensitisa-
tion also mirrors the hypofrontality observed in clinical
populations lending further support to the psychostimu-
lant sensitisation model. These results also hint at the
potential use of low-dose psychostimulant exposure as a
treatment for the cognitive deficits observed in a number
of psychiatric illnesses and the cognitive decline seen with
aging.
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